Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
07/2001
07/25/2001CN1304998A New nucleotide sequence of encode zwal gene
07/25/2001CN1304997A New nucleotide sequence of encode pox B gene
07/25/2001CN1304996A Process for screening taxusol and obtaining cell strains with high output in culturing cells of enqlish yew
07/24/2001US6265640 Nucleotide sequence coding protein associated with plant propagation; for use in controlling reproduction
07/24/2001US6265639 Gymnosperm nucleic acid molecules encoding sesquiterpene synthases and methods of use
07/24/2001US6265638 Method of plant transformation
07/24/2001US6265637 Nucleotide sequence coding polypeptide associated with delayed flowering; for use in the amplification of efficiency of flowering in plants
07/24/2001US6265636 Isolated nucleic acids and their encoded proteins, expression cassettes, host cells, transgenic plants, and antibody compositions, for altering carbohydrate metabolism and/or composition of plants
07/24/2001US6265635 DNA sequences coding for enzymes capable of facilitating the synthesis of linear α-1,4 glucans in plants, fungi and microorganisms
07/24/2001US6265634 Polyribozyme capable of conferring on plants resistance to cucumber mosaic virus and resistant plants producing this polyribozyme
07/24/2001US6265633 Nucleotide sequences which code gene product associated with hops; for amplified quality for beer brewing and for use in generating therapeutics
07/24/2001US6265632 Animal model for fibroblast growth factor receptor associated chondrodysplasia
07/24/2001US6265569 3'-Deoxyribonucleotide derivatives
07/24/2001US6265568 Nucleotide sequences for use in the diagnosis and detection of microorganism infection
07/24/2001US6265567 Isolated FrpB nucleic acid molecule
07/24/2001US6265564 Expressed ligand-vascular intercellular signalling molecule
07/24/2001US6265563 Nucleotide sequences probes for use as diagnostic tools and drug screening
07/24/2001US6265562 Nucleotide sequences coding transcription factor; for the treatment and prevention of infection, tumors, leukemias, autoimmune disease, allergies, arthritis, inflammation, organ rejection, graft versus host disease and coagulation defects
07/24/2001US6265561 Nucleotide sequences which code enzymatic polypeptide; for diagnosis of mammary gland, prostate gland and ovarian cancer
07/24/2001US6265560 Nucleotide sequences coding enzymatic polypeptide associated with signal transducton; for diagnosis, prevention, and treatment of inflammation, arthritis and physiological defects
07/24/2001US6265559 Peptide nucleic acid synthons which have protecting groups which are orthogonal; allows removal of protecting groups under mild conditions; for pna-dna chimeras
07/24/2001US6265558 Compound of linked nucleosides having thiol group attatched at 5-pyrimidine or 2-, 6-, or 8-purine positions; attachment reporter molecules, reporter enzymes, steroids, lipophilic molecules, peptides, proteins and other groups
07/24/2001US6265557 Nucleotide sequences associated with serology; for use in organ transplantion
07/24/2001US6265556 Nucleotide sequences coding mammalian polypeptide associated with immune response and cell propagation; for the detection of modulators of apoptosis
07/24/2001US6265552 Immobilization of protein on surface; transform cell with vector, culture cells, isolate immobilized fusion protein from prepared surface
07/24/2001US6265550 Antibody; for use in the diagnosis, prevention, and treatment of cancer, inflammation, and insulin response defects
07/24/2001US6265548 Preferential protein for use as a tool in genetic engineering
07/24/2001US6265547 Polypeptide for use in diagnosis, treatment, and prevention of cancer, nervous system disorders
07/24/2001US6265545 Reading frame independent epitope tagging
07/24/2001US6265544 Adipocyte-specific protein homologs
07/24/2001US6265543 Polypeptide for the treatment of eye disorders, tumors, cancer, psoriasis, trauma, psychological, burns and ulcers
07/24/2001US6265541 Uses of α-conotoxin peptides
07/24/2001US6265390 Methods for expressing nucleic acid sequences using nucleic acid constructs comprising hypoxia response elements
07/24/2001US6265388 Antisense inhibition of angiogenin expression
07/24/2001US6265378 Protein Z-dependent protease inhibitor
07/24/2001US6265376 Insecticidal plectoxins from plectreurys tristis
07/24/2001US6265224 Sample processing method using ion exchange resin
07/24/2001US6265218 Introducing promoter and heterologous dna encoding a product into plasmid containing antibiotic resistance selection marker, amplifying, using restriction enzymes to form two fragments, cyclizing to form separate plasmids
07/24/2001US6265216 Antisense modulation of cot oncogene expression
07/24/2001US6265215 Isolated peptides which complex with HLA-Cw16 and uses thereof
07/24/2001US6265213 Recombinant plasmid having region which specifically binds to dna-binding molecule, region which binds to restriction enzyme, and restriction site for restriction enzyme; drug screening of compounds affecting transcription factors
07/24/2001US6265212 Making replication-defective adenovirus by transfecting cell having functional e1a and e1b but not pix proteins with nucleic acid having encapsidating signal and inverted terminal repeats, culturing cell and harvesting adenovirus
07/24/2001US6265211 About 105 kilobases; has no detectable alpha satellite dna; mitotically stable; for artificial chromosomes; transgenic plants and animals
07/24/2001US6265206 Method of using bacterial nitrite oxidizer
07/24/2001US6265204 DNA sequences, vectors, and fusion polypeptides for secretion of polypeptides in filamentous fungi
07/24/2001US6265202 Nucleic acid which encodes at least one deosamine biosynthetic enzyme of defined amino acid sequence; recombinant host cell with altered biosynthesis
07/24/2001US6265201 DNA molecules and protein displaying improved triazine compound degrading ability
07/24/2001US6265200 HIV-3 retrovirus and its use
07/24/2001US6265195 Nucleic acid of defined nucleotide sequence which codes for a deoxyribonuclease; for production of enough enzyme for clinical use; diagnosis; treatment of cystic fibrosis, lupus, chronic bronchitis, pneumonia, emphysema, and asthma
07/24/2001US6265194 Dna encoding a polypeptide of defined amino acid sequence; antiproliferative agents; antitumor agents; antipyretics; antiinflammatory agents; immunosuppressants
07/24/2001US6265193 DNA polymerases having improved labeled nucleotide incorporation properties
07/24/2001US6265192 Glycosly sulfortransferase-3
07/24/2001US6265189 Expressing polypeptide in cell culture; insert gene into viral expression vector, transform cells, recover preferential polypeptide
07/24/2001US6265188 Nucleotide sequence coding a enzymatic polypeptide; for use as a wound healing agent; for prevention of bacterial infection
07/24/2001US6265186 Genetically enineered cells for the expression of heterologous proteins
07/24/2001US6265185 Yeast promoters suitable for expression cloning in yeast and heterologous expression of proteins in yeast
07/24/2001US6265184 Polynucleotides encoding chemokine receptor 88C
07/24/2001US6265183 Direct molecular cloning of foreign genes into poxviruses and methods for the preparation of recombinant proteins
07/24/2001US6265177 Enzyme assay for mutant firefly luciferase
07/24/2001US6265175 Incubating components comprising neuroblast and composition to be tested for ability to stimulate or inhibit proliferation or differentiation of the neuroblast to allow composition to bind to neuroblast, culturing, detecting effect
07/24/2001US6265174 Methods and compositions for identifying and modulating ctionprotein-interactions
07/24/2001US6265173 Methods of modulating the expression of genes using ultraspiracle receptor
07/24/2001US6265171 Method of detection of methylated nucleic acid using agents which modify unmethylated cytosine and distinguish modified methylated and non-methylated nucleic acids
07/24/2001US6265170 Homogenous assay of duplex of triplex hybridization by means of multiple measurements under varied conditions
07/24/2001US6265169 Method based on the use of bacteriophages for the detection biological molecules in biological samples
07/24/2001US6265167 Targeted RNA degradation using nuclear ribozyme RNA
07/24/2001US6265165 Amplifing and sequencing preferential nucleotide sequences; prepare primers, obtain preferential nucleotide sequences, purify nucleotide sequences, isolate nucleotide sequences, clone, transform into cells, detect sequences in cells
07/24/2001US6265164 Compositions and methods for directly and rapidly analyzing the biochemical components of microorganisms
07/24/2001US6265163 Solid phase selection of differentially expressed genes
07/24/2001US6265159 Method for producing DNA nested deletions by an in vitro reaction using transposase
07/24/2001US6265158 Nucleotide sequences associated with genetic disorders; for the detection and diagnosis of preferential genetic disorders
07/24/2001US6265155 Metallic solid supports modified with nucleic acids
07/24/2001US6265154 Oligonucleotide mixture for detecting viral infection; for the diagnosis and treatment of cancer
07/24/2001US6265153 Adhering nucleotide sequences to a support; incubate nucleotide sequences with solid support, move slowly through curved surface of fluid, analyze the surface of support for fixed nucleotide sequences
07/24/2001US6265021 Laminar layered structure
07/24/2001US6264957 Product of infectious respiratory syncytial virus from cloned nucleotide sequences
07/24/2001US6264955 Ferrichrome transport ATP-binding protein
07/24/2001US6264954 Immunogenic peptide
07/24/2001US6264953 Method of preparation and use for zona pellucida antigens and antibodies for sterilization and contraception
07/24/2001US6264951 Administering polypeptide
07/24/2001US6264950 Complex of protein and immunoglobulin
07/24/2001US6264947 Genetic engineering; therapy for cancer, autoimmune diseases, reproduction, antiinflammatory agents
07/24/2001US6264942 Bacillus thuringiensis containing compositions
07/24/2001US6264941 Compositions for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules
07/24/2001US6264940 Antitumor, anticancer agent
07/24/2001CA2205006C Modified green fluorescent proteins
07/24/2001CA2040810C Process for producing foreign proteins in streptomyces
07/24/2001CA2039030C Microorganisms and process for producing biotin vitamers using the same
07/24/2001CA2037291C Dna fragment encoding a polypeptide having nitrile hydratase activity, a transformant containing the gene and a process for the production of amides using the transformant
07/24/2001CA2033355C Cloning host organisms
07/24/2001CA2024629C Xenopus laevis bone morphogenic protein, dna encoding same and use thereof
07/19/2001WO2001051922A2 Identification of peripheral benzodiazepine receptor binding agents
07/19/2001WO2001051689A1 Biomolecules having multiple attachment moieties for binding to a substrate surface
07/19/2001WO2001051672A2 System and method for controlling male fertility
07/19/2001WO2001051668A1 Ferrofluid based arrays
07/19/2001WO2001051666A1 Methods for diagnosing and treating heart disease
07/19/2001WO2001051665A2 Nanoparticles having oligonucleotides attached thereto and uses therefor
07/19/2001WO2001051664A2 Method of detecting and characterizing a neoplasm
07/19/2001WO2001051663A2 Integrated systems and methods for diversity generation and screening
07/19/2001WO2001051662A1 A method for detection of pathogenic organisms